The mechanisms by which hypoglycemia stimulates glucagon release are still poorly understood. In particular, the relative importance of direct metabolic coupling versus paracrine regulation by ␤-cell secretory products is unresolved. Here, we compare the responses to glucose of 1) ␣-cells within the intact mouse islet, 2) dissociated ␣-cells, and 3) clonal ␣TC1-9 cells. G lucagon is the key counterregulatory hormone responsible for opposing the glucose-lowering effects of insulin (1). Thus, glucagon stimulates both glycogen breakdown and gluconeogenesis by the liver (2) while decreasing hepatic triglyceride synthesis (3,4). Appropriate stimulation of glucagon release from pancreatic islet ␣-cells is particularly important to minimize the impact of acute insulin-induced hypoglycemia, a major complication and the cause of 2-4% of all deaths in type 1 diabetes (5,6).
G
lucagon is the key counterregulatory hormone responsible for opposing the glucose-lowering effects of insulin (1) . Thus, glucagon stimulates both glycogen breakdown and gluconeogenesis by the liver (2) while decreasing hepatic triglyceride synthesis (3, 4) . Appropriate stimulation of glucagon release from pancreatic islet ␣-cells is particularly important to minimize the impact of acute insulin-induced hypoglycemia, a major complication and the cause of 2-4% of all deaths in type 1 diabetes (5, 6) .
Glucagon release is normally stimulated as blood glucose concentrations fall, a response that is progressively diminished in type 1 diabetes (7, 8) . This loss of responsiveness, which leads to increased incidence and severity of hypoglycemia with time, does not involve an apparent change in total ␣-cell mass (9,10) but rather the development of "hypoglycemia blindness" in existing ␣-cells.
Although the molecular mechanisms involved in the regulation of insulin secretion are increasingly well understood (11) (12) (13) , knowledge of those that mediate the inhibition of glucagon release remains fragmentary. In particular, the respective roles of 1) glucose, acting directly on individual ␣-cells; 2) insulin (5, 14, 15) ; or 3) other factors, including ␥-aminobutyric acid (16) secreted from neighboring ␤-cells, are uncertain, as is 4) the contribution of autonomic inputs (5) . Against an important role for a paracrine mechanism, the stimulation of glucagon release from the perfused rat pancreas after a decrease (5.5-4.4 mmol/l) in glucose concentration was unaffected by perfusion with anti-insulin antiserum (17) . Similarly, a larger decrease in glucose concentration (5.5-1.4 mmol/l) prompted the same increment in glucagon release in pancreata from control or streptozotocin-induced diabetic rats (18) . On the other hand, retrograde perfusion at slightly elevated glucose concentrations increased both insulin and glucagon release, suggesting an inhibitory role for ␤-cell factors at elevated glucose concentrations (19) . Moreover, cessation of ␤-cell secretion is required for the activation of glucagon release during hypoglycemia in rats (20) . Finally, a recent study (21) implicated the release of Zn 2ϩ ions from ␤-cells, based on the ability of micromolar concentrations of these ions to reverse the stimulatory effects of pyruvate on glucagon release from the perfused rat pancreas and the reversal of the effects of monomethyl succinate with calcium EDTA, a broad-range divalent metal ion chelator.
Glucose-induced increases in total cellular ATP content and in the ATP-to-ADP(AMP) ratio have been reported in isolated pancreatic ␤-cells (22) as well as rodent islets (23) (24) (25) . These increases seem likely to inhibit ATP-sensitive K ϩ channels (K ATP channels) (12) and to inhibit AMP-activated protein kinase (26) . Whereas the former leads to plasma membrane depolarization, Ca 2ϩ influx, and the activation of vesicle fusion at the cell surface (27) , the latter may allow vesicle mobilization and sustained insulin secretion (28) . Correspondingly, total islet ATP content (24, 29) and free ␤-cell ATP (30 -32) increase in response to glucose. By contrast, no changes in total ATP were reported in purified rat ␣-cells at elevated glucose concentrations (22) confounding effects of ␤-cell products can be reduced or eliminated.
We show that 1) glucose increases [ATP] c in ␣-cells both within the islet and in clonal ␣TC1-9 cells, implying a direct effect of the sugar on ␣-cell oxidative metabolism; 2) glucose and insulin, but not IGF-1, inhibit Ca 2ϩ oscillations in isolated or clonal ␣-cells; and 3) release of Zn 2ϩ ions is unlikely to mediate the effects of ␤-cell activation on glucagon release from mouse ␣-cells.
RESEARCH DESIGN AND METHODS
Adenoviruses were constructed and amplified, using the pAdEasy system (34) as previously described (31) . The 1.6-kb rat PPG promoter was digested using SacI and subcloned into pEGFP-C2 (Clontech). The resulting plasmid was then digested with XhoI/HindIII and transferred into pShuttle (pShuttle-PPG). cDNA encoding cytosolic luciferase (pGL3-Basic; Promega) was digested with HindIII/SalI and transferred into pShuttle-PPG (pShuttle-PPG-Luc). cDNA encoding cytosolic ratiometric pericam (33) was digested with HindIII/XbaI, and the restricted fragment was subcloned into pGL3-Basic. The resulting plasmid was then partially digested using HindIII/SalI and transferred into pShuttle-PPG (pShuttle-PPG-ratiometric pericam). Recombination with pAdEasy-1, transfection into HEK 293 cells, and viral amplification were performed as described (31) . Preparation, solutions, and adenoviral infection. ␣TC1-9 cells (passage 35-45; American Type Culture Collection) were grown in Dulbecco's modified Eagle's medium containing (in mmol/l): 18 NaHCO 3 , 16 glucose, 0.1 nonessential amino acids, 10% heat-inactivated FCS, 100 IU/ml penicillin, and 100 g/ml streptomycin. Islets were aseptically isolated by collagenase digestion of the pancreas of female CDI mice and selected by hand-picking. Islets were then cultured for 1 day in RPMI 1640 medium containing 10 mmol/l glucose, 10% heat-inactivated FCS, 100 IU/ml penicillin, and 100 g/ml streptomycin (35) . To obtain clusters or single cells, islets were dissociated after incubation for 5 min in Ca 2ϩ -free medium. After brief centrifugation, this solution was replaced by culture medium, and the islets were disrupted by gentle pipetting through a siliconized glass pipette. Clusters and single cells were then cultured for 1 day on circular glass coverslips. The control medium (KrebsRinger bicarbonate buffer [KRBB]) used for islet isolation contained (in mmol/l) 120 NaCl, 4.8 KCl, 2.5 CaCl 2 , 1.2 MgCl 2 , 24 NaHCO 3 , 10 glucose, and 1 mg/ml BSA and was gassed with O 2 /CO 2 (95/5) to maintain a pH of 7.4. The same medium was used for all imaging experiments. Where the concentration of KCl was increased to 30 mmol/l, the concentration of NaCl was decreased accordingly to maintain iso-osmolarity. ␣TC1-9 cells and islets or dispersed islet cells (2nd day of culture) were infected with adenovirus at a multiplicity of infection of 50 -100 infectious particles per cell for 4 h, and then the medium was changed. Imaging was performed 2-3 days after infection. Measurement of [ATP] c . Changes in [ATP] c were measured in mouse ␣-cells within intact islets or in ␣TC1-9 cells after infection with PPG-luciferase adenovirus. Cells were perifused in KRBB containing 100 mol/l beetle luciferin and imaged at 37°C using a single-cell photon-counting imaging device (ICCD218 intensified camera; Photek, Lewes, U.K.) (31) mounted on an Olympus IX-70 microscope fitted with a 10ϫ objective lens. Photon release was monitored continuously at a video rate (60 frames/s) and data pooled over 10 s followed by three points moving average were performed off-line to optimize the signal-to-noise ratio (30) . filtered at 535 nm. The ratio images were used to calculate [Ca 2ϩ ] c off-line, as previously described (33). Measurement of glucagon and insulin secretion. Islets (2nd day of culture) or ␣TC1-9 cells were preincubated for 1 h at 37°C in control KRBB medium containing 10 mmol/l glucose. Islets were then distributed in batches of six and incubated for 1 h in 400 l of medium containing test substances, whereas ␣TC1-9 cells were incubated for 30 min in 700 l in a 12-well plate. At the end of experiments, an aliquot (350 l) of the medium was taken and saved until glucagon and insulin were measured by radioimmunoassay (Linco Research, St. Charles, MO). Immunocytochemistry. Cells were fixed and incubated with primary and secondary antibodies as previously described (36) . Glucagon was probed with polyclonal rabbit anti-glucagon antibody (1:250; DakoCytomation, Cambridgeshire, U.K.) and revealed with Alexa Fluor 568 goat anti-rabbit IgG (1:3,000; Molecular Probes, Eugene, OR). Images were captured on a Leica SP2 laser-scanning confocal microscope using a 63ϫ oil immersion objective. Statistical analysis. Data are the means Ϯ SE for the number of observations indicated. Statistical significance and differences between means were assessed by Student's t test (paired or unpaired, as appropriate) or by ANOVA followed by a Newman-Keuls test when more than two groups were compared.
Measurement of cytosolic concentration of Ca

RESULTS
Imaging ␣-cell ATP concentration in the intact islet. Expression of luciferase under the control of the rat PPG promoter (PPG-Luc) led to efficient expression of the photoprotein in islets (Fig. 1A) . Because we could not perform immunocytochemistry for luciferase on islets due to antibody cross-reactivity, we compared the ability of the PPG-Luc virus to infect clonal ␣-versus ␤-cells. In six independent experiments, 56% of ␣TC1-9 cells were infected with PPG-Luc and 56% with CMV (cytomegalovirus)-Luc (i.e., 100% efficiency after normalization). By contrast, 7% of MIN6 ␤-cells were infected with PPG-Luc versus 55% with CMV-Luc (13% efficiency after normalization), demonstrating ␣-cell selectivity, and this was consistent with ␣-cell-restricted expression of the pericam probe (see below).
We used photon-counting imaging to monitor the effect of glucose on luciferase luminescence, and hence [ATP] c (30 -32) , within ␣-cells in individual islets. Although this technique did not allow resolution at the level of individual cells over short integration times (10 -20 s), recordings could nevertheless be made from the surface of the whole islet with a resolution of ϳ30 m, corresponding to 1-6 single ␣-cells (Fig. 1A) . Increasing the glucose concentration from 0 to 20 mmol/l increased the luminescence from ␣-cell-localized luciferase by 9% (100 Ϯ 0.5 vs. 109 Ϯ 3.0 units, P Ͻ 0.01) (Fig. 1B) . Consistent with previous measurements in groups of islets (21) (Fig. 1E and F) , whereas an increase from 3 to 20 mmol/l glucose did not produce any further increase in [ATP] c (Fig. 1G ). The addition of 17 nmol/l insulin either in the absence (Fig. 1H ) or in the presence (not shown) of glucose (3 mmol/l) failed to elicit any change in [ATP] c .
Regulation of Ca
2؉ dynamics by glucose in isolated primary ␣-cells. To determine whether glucose may be able to affect intracellular [Ca 2ϩ ] c in the absence of ␤-cell secretory products, we used a recombinant ratiometric pericam (33,37) expressed under the control of the PPG promoter (PPG-pericam). As expected, the ratiometric pericam was targeted efficiently and almost exclusively to glucagon-positive ␣-cells (26 of 28 cells examined, 93%) ( Fig. 2A) , allowing selective measurements of [Ca 2ϩ ] c in this cell type.
To infect individual ␣-cells, mouse islets were dispersed ] c value (2 of 8 cells) (Fig. 2B) or detectable [Ca 2ϩ ] c oscillations (6 of 8 cells) (Fig. 2C) . In nonoscillating ␣-cells, a decrease in glucose concentration from 20 to 0.5 mmol/l induced oscillations of [Ca 2ϩ ] c (2 of 8 cells) (Fig. 2B) , a response similar to that observed in mixed clusters of ␣-and non-␣-cells (see below) (Fig. 5D) . By contrast, in cells already displaying oscillations, the frequency was either increased by Ն15% (4 of 6 cells) (Fig.  2C ) or remained unchanged (2 of 6 cells) (Fig. 2D) , whereas the amplitude of oscillations was not affected (Fig. 2C  and D) . The addition of 30 mmol/l K ϩ induced either a sustained (56%) or a transient (31%) increase of [Ca 2ϩ ] c in almost all (14 of 16, 88%) ␣-cells examined, even in nonglucose-responsive cells.
2؉ dynamics by glucose in clonal ␣TC1-9 cells. To investigate further the ability of glucose to influence Ca 2ϩ oscillations in the ␣-cell in the absence of ␤-cells, we used clonal mouse ␣TC1-9 cells. As shown in Fig. 3A , ϳ50% of ␣TC1-9 cells displayed clear oscillations in [Ca 2ϩ ] c in the complete absence of exogenous glucose, with a frequency of 0.1-2.4 oscillations/min. These [Ca 2ϩ ] c oscillations were either completely suppressed or markedly decreased in frequency when glucose concentrations were raised (Fig. 3 and 5A) , demonstrating a direct effect of the sugar that did not require the release of ␤-cell products. Analysis of the dose response for these effects ( Fig. 3B and 5A ) revealed saturation at glucose concentrations Ͼ3-5 mmol/l.
Effects of insulin and Zn
2؉ ions on Ca 2؉ dynamics in ␣TC1-9 cells and primary mouse ␣-cells. We next sought to determine whether there may be a separate role for insulin, or cosecreted Zn 2ϩ ions, to potentiate the above direct effects of glucose. Added to ␣TC1-9 cells in the absence of glucose, where [Ca 2ϩ ] c oscillations were maximally stimulated, low concentrations (1.7-17 nmol/l) of insulin led to complete or partial suppression of [Ca 2ϩ ] c transients ( Fig. 4A and B) . The effects of insulin were also apparent at 0.5 mmol/l glucose, but they were no longer evident as the glucose concentration was raised to 1 or 20 mmol/l (Fig. 4B) . Consistent with the actions of insulin via classical insulin receptors, and signal transduction via phosphatidylinositol 3Ј kinase, the effects of the hormone were not mimicked by IGF-1 but were suppressed by 
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100 nmol/l wortmannin (Fig. 4B ) or LY294002 (data not shown). Figure 5A illustrates the decrease in frequency of [Ca 2ϩ ] c oscillations at a given glucose concentration in the presence or absence of insulin. Insulin decreased the frequency of [Ca 2ϩ ] c oscillations at 0 or 0.5 mmol/l to the same extent as was observed at 1 mmol/l glucose in the absence of insulin, indicating that the effects of insulin and glucose were not additive.
To determine whether the effects of insulin might largely be explained by the presence of cocrystallized Zn 2ϩ ions (insulin contained ϳ0.5% zinc), we added 0.7 nmol/l ZnCl 2 , the concentration present after the dissolution of 1.7 nmol/l insulin. This maneuver exerted no effect on the frequency of Ca 2ϩ oscillations in clonal ␣TC1-9 cells (100 Ϯ 13 vs. 92 Ϯ 15, NS) (Fig. 5B) . Similarly, at either 0 or 20 mmol/l glucose, 30 mol/l of ZnCl 2 (as used previously in the perfused pancreas) (21), exerted either no effect or had a minor stimulatory action on the frequency of Ca 2ϩ oscillations in the presence or absence of 17 nmol/l insulin in ␣TC1-9 cells (Fig. 5C) . Similar results were obtained in isolated primary mouse ␣-cells: insulin either completely suppressed (Fig. 5D) (Fig. 5D) .
Effects of glucose, insulin, and Zn
2؉ on glucagon secretion from ␣TC1-9 cells and islets. Glucagon secretion from ␣TC1-9 cells was dose-dependently decreased by glucose (Fig. 6A) and, in common with the observed [Ca 2ϩ ] c oscillations, significant inhibition was observed at glucose concentrations Ն1.0 mmol/l (P Ͻ 0.05). It is important to note that the release of insulin from ␣TC1-9 cells was essentially undetectable (Յ50 pg ⅐ ml Ϫ1 ⅐ h Ϫ1 ⅐ well
Ϫ1
) and was not affected by an increase in glucose concentration (not shown), consistent with a wellpreserved ␣-cell phenotype. Again, the addition of insulin decreased glucagon secretion in the absence of glucose to approximately the same extent as 1 mmol/l glucose (Fig.  6A, Table 1 ), and the effects of insulin on glucagon secretion were suppressed by 100 nmol/l wortmannin (Table 1) . Note, however, that the ␣TC1-9 cells used in this study displayed a left shift in the responses to glucose compared with primary ␣-cells in terms of [ATP] c , [Ca 2ϩ ] c , and glucagon secretion (see below).
The release of glucagon from primary mouse islets was dose-dependently decreased in the presence of glucose, although in this case the main inhibitory effect was observed between 3 and 5 mmol/l (Fig. 6B) , a range of glucose concentrations that did not stimulate insulin secretion (Fig. 6D) . These results are consistent with the range over which glucagon release is suppressed in vivo (18) . As in ␣TC1-9 cells, insulin (17 nmol/l) suppressed glucagon secretion from intact islets, and these effects were completely reversed by the phosphatidylinositol 3Ј-kinase inhibitor wortmannin (Fig. 6B and C, Table 2 ). Wortmannin, in the absence of insulin, also tended to increase slightly the release of glucagon, possibly as a result of the suppression of an inhibitory effect of basal insulin release (66 pmol/l) at 0.5 mmol/l glucose ( Fig. 6C and D) . However, even in the presence of wortmannin, 10 mmol/l glucose still inhibited glucagon secretion, consistent with a direct, insulin-independent effect of the sugar on ␣-cells (Fig. 6C) . impact on glucagon secretion in either the absence or the presence of insulin and/or elevated glucose concentration.
DISCUSSION
Use of targeted luciferase to image free [ATP] c in ␣-cells. We demonstrate here the feasibility of imaging recombinant probes delivered selectively to either primary or clonal mouse ␣-cells under the control of the PPG gene promoter. We show firstly that fluctuations in luciferase luminescence may be used as a guide to intracellular free ATP concentrations in ␣-cells within the intact islet, as well as in clonal ␣-cells, as previously reported for ␤-cells (30, 32) . In the present studies, no attempt was made to provide a calibration of absolute free ATP concentrations in the ␣-cell. When such calibrations are performed after cell permeabilization (30) , there are in any case considerable uncertainties as to the intracellular concentrations of luciferin and other luciferase regulators. However, total ATP concentrations have been reported to be ϳ2 mmol/l in ␣TC1-6 cells (38), compatible with free ATP concentrations (comprising ATP 4Ϫ and Mg-ATP 2Ϫ ) in the range of 1-2 mmol/l (22) .
Luciferase imaging revealed that glucose is able, in the absence of changes in ␤-cell secretion, to increase free cytosolic ATP concentrations in ␣-cells. This result is in apparent contrast to measurements of total cellular ATP content made in fluorescence-activated cell-sorted rat ␣-cells (22) , but it is consistent with measurements of ␣-cell-restricted luciferase luminescence in rat islet populations (21) . The magnitude of the observed increases (7-9% in primary ␣-cells in the intact islet, ϳ4% in ␣TC1-9 cells) was, however, significantly lower than those recorded in either ␤-cells within the intact islet or clonal MIN6 cells, possibly reflecting the poorer capacity for oxidative metabolism of ␣-versus ␤-cells (39, 40) . Intracellular mechanisms involved in the regulation of ␣-cell Ca 2؉ homeostasis by glucose. Using an ␣-celltargeted pericam, we analyzed here intracellular Ca 2ϩ oscillations in primary and clonal mouse ␣-cells. Using this approach, we provide evidence that glucose is able to directly influence the activity of ␣-cells in the absence of ␤-cell secretory factors. Thus, although we were unable to compare the efficiency of glucose to suppress Ca 2ϩ oscillations in isolated ␣-cells versus ␣-cells within the intact islet (because of interference from ␤-cell autofluorescence in the latter case) (data not shown), the finding that a decrease in glucose concentration accelerated oscillations in most isolated ␣-cells is in line with previous observations that Ca 2ϩ oscillations are inhibited in ϳ19% of all cells within the intact islet (41) . Importantly, we demonstrate here for the first time that glucose and insulin modulate the frequency of Ca 2ϩ oscillations in clonal mouse ␣-cells. This contrasts with earlier reports in lnR1-G9 glucagonoma cells (42) , where nutrients were found principally to affect the amplitude of oscillations. Although the sample sizes in both the current and an earlier (41) study were not sufficiently large to quantify the changes in primary mouse ␣-cells, such frequency modulation nonetheless provides a potential mechanism through which glucose may regulate the pulsatile release of glucagon.
What intracellular signaling mechanisms may mediate the effects of glucose on ␣-cell Ca 2ϩ ? Several are possible. First, K ATP channels may close as ATP concentrations (or the ATP-to-ADP ratio) increase. This has been proposed (43, 44) to lead to the inactivation of Na ϩ channels and thus the inhibition of action potentials. However, we observed little if any response to 500 mol/l tolbutamide, the K ATP channel blocker, in clonal ␣-cells (M.A.R and G.A.R., unpublished observations), which is consistent with previous reports that these channels are scarce (45) or insensitive to tolbutamide and diazoxide in mouse ␣-cells, at least at basal glucose concentrations (3 mmol/l) (15, 46, 47) . On the other hand, electrical and secretory responses to glucose are lost in ␣-cells from SUR1 Ϫ/Ϫ mice (44), arguing for an important role for these channels. Nevertheless, it is conceivable that additional sensors of cellular energy charge, such as AMP-activated protein kinase (26, 48) , are involved, as recently described for glucose-inhibited hypothalamic neurons (49) . Alternatively, increases in ATP may also lower [Ca 2ϩ ] c by activating Ca 2ϩ pumps, which in turn inhibit store-operated Ca 2ϩ channels (46) . Roles of ␤-cell secretory factors in regulating glucagon release. The present studies considered the possibilities 1) that the effects of glucose on glucagon release are indirect and mediated largely by insulin (or another ␤-cellderived factor) and 2) that they are direct, but that paracrine factors additionally affect glucagon release when glucose concentrations are low. With regards to the former, our findings indicate that glucose stimulates ␣-cell oxidative metabolism directly, elevating [ATP] c and in turn suppressing glucagon release. By contrast, Ishihara et al. (21) proposed that in the absence of a factor(s) secreted from ␤-cells, enhancement of ␣-cell metabolism by glucose would stimulate glucagon release. Although the reasons for these divergent conclusions are unclear, the current data argue that the release of a ␤-cell-derived factor is unlikely to be essential to inhibit glucagon release in response to glucose. Thus, the inhibitory effects of glucose were observed here both in ␣TC1-9 cells, where an effect of ␤-cell factors is excluded, and in mouse islets when insulin signaling was blocked with wortmannin ( Fig.  6C) . Correspondingly, glucagon secretion was fully inhibited at glucose concentrations (Ͻ5 mmol/l) that were clearly lower than those that began to stimulate the secretion of insulin (Ͼ5 mmol/l) (Fig. 6B vs. D) and presumably other ␤-cell factors. Concerning the possibility that the effects of glucose on glucagon are direct but that paracrine factors additionally affect glucagon release, insulin was found here to suppress glucagon release in the absence of glucose. Whereas the physiological relevance of this phenomenon is uncertain, it may ensure that insulin released in response to metabolizable amino acids such as leucine prevents the simultaneous activation of glucagon secretion (50) .
In further contrast to recent observations in the perfused rat pancreas (21), we observed no or only small stimulatory effects of ZnCl 2 on [Ca 2ϩ ] c transients and glucagon release from either mouse ␣TC1-9 cells or mouse islets. One possible explanation for this apparent difference between rat and mouse is that the effects of Zn 2ϩ ions may be mediated in the former case through a K ATP channel-dependent mechanism, given that these channels are relatively abundant in rat, but not mouse, ␣-cells (see above). It is also conceivable that other targets for Zn 2ϩ action, including ␥-aminobutyric acid receptors (16, 51) , are important: although these have been characterized in part in rat ␣-cells (52), data are currently unavailable for mouse ␣-cells.
